EUROPACOLON

What EUROPACOLON does

EuropaColon is a pan-European, non-profit patient advocacy organization headquartered in Salisbury, United Kingdom, with a registered office (Company No. 5314195). It was established to unite patients, caregivers, healthcare professionals, politicians, the media, and the public in the fight against digestive cancers, and is recognised as the voice of colorectal cancer patients in Europe. The organization operates a federation model through a network of 43 affiliate patient groups across 32 European countries, delivering awareness campaigns such as the European Colorectal Cancer Awareness Month (ECCAM), the annual Advocacy Masterclass held alongside ESMO's World Congress on Gastrointestinal Cancer, structured patient surveys (metastatic colorectal cancer, oesophageal/gastric cancer) with outputs published in peer-reviewed journals, and a Patient Voice platform of survivor testimonials.

Its core deliverables are educational and advocacy services rather than technology products: multilingual downloadable resources on prevention, screening, treatment, and clinical trials; the Inflatable Colon educational tool deployed at events; patient rights advocacy via the Charter of Patients' Rights and the European Patients' Rights Day in partnership with Active Citizenship Network; and clinical-trial information curation pointing patients to external registries including ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform. The organization also extends into clinical research partnerships such as the MErCuRIC phase Ib/II trial consortium (with Cancer Research UK and European research institutions) and the Patient Partner Europe Consortium.

EuropaColon does not sell products or services and provides all resources free of charge to patients and caregivers. Its revenue model rests on membership-style contributions from affiliate patient groups, grants, and pharmaceutical sponsorship (e.g., Merck KGaA content support for caregiver stories), with no publicly disclosed pricing, ARR, or revenue figures. Go-to-market is community- and influence-led rather than commercial, relying on social media (Facebook, Twitter, YouTube), monthly newsletters, media relations, and event-based engagement. Leadership comprises CEO Jola Gore-Booth and Director Zorana Maravic, supported by a small staff of 6 employees.

Name

EUROPACOLON

Legal name

EuropaColon

Website

https://europacolon.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

EuropaColon is a pan-European non-profit patient advocacy organization headquartered in Salisbury, UK, uniting 43 affiliate groups across 32 countries to advocate for digestive cancer patients through awareness campaigns, education, peer-reviewed patient surveys, and EU-level policy work.

Ownership category

akta.pro rank

Headquarters

HQ city

Salisbury

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership contributions: EuropaColon operates as a membership-based pan-European organization uniting patient groups, caregivers, healthcare professionals, politicians, and media. Membership fees likely contribute to organizational funding.

Distribution channels3 records

Marketing channels7 records

Core offering

EuropaColon is a pan-European patient advocacy non-profit that provides free educational resources, awareness campaigns, patient surveys, advocacy training, and patient rights support for people affected by colorectal and other digestive cancers. Its service portfolio includes multilingual fact sheets and guides, the annual Advocacy Masterclass, the European Colorectal Cancer Awareness Month (ECCAM), the Patient Voice storytelling platform, a clinical trials information service, and policy advocacy at the EU level, all distributed through an affiliate network of 43 patient groups in 32 European countries.

Product overview

EuropaColon is a pan-European patient advocacy organization united against digestive cancers. The organization operates as a federation of 43 patient groups across 32 European countries, functioning as the recognized voice of colorectal cancer patients in Europe. Its service portfolio includes patient education and information resources (fact sheets, guides, and multilingual materials on colorectal cancer, screening, and treatment), patient surveys to understand unmet needs in metastatic colorectal cancer and gastric cancers, an annual Advocacy Masterclass training program, the European Colorectal Cancer Awareness Month (ECCAM) campaign, a Patient Voice storytelling platform featuring survivor testimonials, clinical trial information services, and patient rights advocacy work. The organization also supports digestive cancers beyond colorectal cancer, including pancreatic and stomach cancers.

Differentiator

Problem solved

Functional benefit

Brands

• United Against Digestive Cancers: Campaign slogan/tagline used by EuropaColon representing their broader mission beyond colorectal cancer

Products and services

• Patient Education and Information Services
• Metastatic Colorectal Cancer (mCRC) Patient Survey
• Oesophageal/Gastric Cancer Patient Survey
• EuropaColon Advocacy Masterclass
• European Colorectal Cancer Awareness Month (ECCAM)
• Patient Voice Platform
• Clinical Trials Information Service
• Patient Rights Advocacy

Quantifiable outcome

• Patient survey results published in Annals of Oncology regarding unmet needs of metastatic colorectal cancer patients
• +1 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• Global Colon Cancer Association (GCCA)coreStrategic or Co-development PartnerGCCA is a partner organization featured on EuropaColon's homepage. Both organisations share the mission of reducing colorectal cancer mortality and work together on awareness initiatives. The partnership strengthens the global patient voice in colorectal cancer advocacy.
• Inflatable Colon (IBorgans)coreStrategic or Co-development PartnerThe Inflatable Colon is a unique educational tool developed to break down taboos surrounding colorectal cancer. EuropaColon partners with IBorgans to use this visual tool at events and awareness campaigns across Europe to educate the public about the disease.
• Global Health Education Partnership (GHEP)minorStrategic or Co-development PartnerGHEP partnership focuses on global health education initiatives related to digestive cancers and prevention awareness.
• Active Citizenship NetworkcoreStrategic or Co-development PartnerActive Citizenship Network developed the Charter of Patients' Rights with 15 national citizens' organisations. EuropaColon collaborates on the VIII European Patients' Rights Day and advocates for patient rights protection across EU member states. The Charter is grounded in the European Charter of Fundamental Rights.
• Bowel Cancer UKcoreChannel Partner/ Reseller/ DistributorBowel Cancer UK is listed as an associate of EuropaColon and shares patient stories. Several patient testimonials on EuropaColon's site reference Bowel Cancer UK as a support resource. The organisations collaborate on awareness campaigns including ECCAM.
• Patient Partner Europe ConsortiumcoreStrategic or Co-development PartnerCollaborative project with Dutch Genetic Alliance, The European Genetic Alliances Network, The Genetic Interest Group, and European Forum of Good Clinical Practice. The project aims to open dialogue between patient organisations, pharma, and academia on patient partnering in clinical trials, ultimately producing practical guidelines.
• MErCuRIC Project ConsortiumminorStrategic or Co-development PartnerEuropaColon participates in MErCuRIC, a multicenter phase Ib/II clinical trial assessing novel therapeutic strategies combining MEK and MET inhibitors for colorectal cancer patients with KRAS mutations. Collaboration includes Cancer Research UK and European research institutions.
• ESMO (European Society for Medical Oncology)coreStrategic or Co-development PartnerEuropaColon's 3rd Advocacy Masterclass was held alongside ESMO's 20th Anniversary World Congress on Gastrointestinal Cancer in Barcelona from 21-23 June 2018. The partnership provides educational content on gastrointestinal cancers to patient advocates.

Scale indicators2 records

Recent moves1 record

Expansion highlights4 records

Direct peers

• Bowel Cancer UK: UK-based colorectal cancer charity providing patient support, research funding, and awareness campaigns. A direct peer in CRC advocacy and a listed EuropaColon associate with shared patient stories and ECCAM collaboration.
• Fight Colorectal Cancer: US-based CRC patient advocacy organisation running awareness, policy, and research-grant programmes. Direct peer operating a near-identical mission in a different geography.
• Pancreatic Cancer UK: UK charity dedicated to pancreatic cancer, one of the digestive-cancer verticals EuropaColon has expanded into. Comparable in patient-advocacy, awareness, and research-funding model.
• Colorectal Cancer Alliance: Largest US CRC-focused non-profit combining patient support, screening navigation, and research funding. Closely comparable in mission, awareness programming, and patient-services portfolio.
• European Cancer Patient Coalition (ECPC): Europe's largest umbrella cancer patient organisation, covering all cancer types. Comparable as a pan-European policy/advocacy umbrella with overlapping EU-level screening and patient-rights agenda.
• Global Colon Cancer Association (GCCA): Global umbrella for colon cancer patient organisations; a featured EuropaColon homepage partner with an aligned mission of reducing colorectal cancer mortality worldwide. Closest analogue as a federated CRC advocacy body.
• Digestive Cancers Europe (DiCE): European umbrella for digestive cancer patient organisations covering colorectal, pancreatic, gastric, and other GI cancers. Directly comparable to EuropaColon's expanded digestive-cancers remit.

Broad incumbents

• Cancer Research UK: UK's largest cancer research and awareness charity with a substantially broader remit and budget. Operates overlapping screening-awareness and patient-information programmes but is not CRC-specialised.
• Macmillan Cancer Support: UK cancer-support charity providing information, financial, and emotional support across all cancer types. Comparable patient-support model with much larger scale and broader remit.

Others

• Active Citizenship Network: EU-level citizens' rights organisation co-developing the Charter of Patients' Rights with EuropaColon. Adjacent peer on patient-rights advocacy rather than cancer-specific services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key highlights7 records

Customer concentration

• Xx.com/europacolon
• YouTubeyoutube.com/channel/UCdM78H48-DNsoSa6Qo9BBjQ?view_as=subscriber
• Facebookfacebook.com/europacolonhq
• LinkedInlinkedin.com/company/europacolon

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EUROPACOLON